LAVA Therapeutics Q1 EPS $(0.02) Beats $(0.12) Estimate, Sales $6.99M Miss $7.00M Estimate
LAVA Therapeutics Q1 EPS $(0.02) Beats $(0.12) Estimate, Sales $6.99M Miss $7.00M Estimate
LAVA Therapeutics第一季度每股收益美元（0.02美元）超过预期（0.12美元），销售额为699万美元，低于700万美元的预期
LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.23 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $6.99 million which missed the analyst consensus estimate of $7.00 million by 0.11 percent. This is a 471.24 percent increase over sales of $1.22 million the same period last year.
LAVA Therapeutics（纳斯达克股票代码：LVTX）公布的季度亏损为每股0.02美元，比分析师共识估计的美元（0.12美元）高出83.33％。这比去年同期每股亏损0.53美元（0.53）增长了96.23％。该公司公布的季度销售额为699万美元，比分析师普遍预期的700万美元低0.11％。这比去年同期的122万美元销售额增长了471.24％。